CINPHA — Cinclus Pharma Holding publ AB Share News
0.000.00%
Last trade - 00:00- SEK530.79m
- SEK107.87m
- SEK57.47m
Brief: Cinclus Pharma Enters Into EUR 28 Mln Financing Agreement
Brief: Cinclus Pharma Says FDA Clarifies Pivotal Study
Brief: Cinclus Pharma Proposes No Dividend
Brief: Cinclus Pharma Gets Positive Assessment From FDA
Brief: Cinclus Pharma Receives Regulatory Support
Brief: Cinclus Pharma Linaprazan Glurate Gets Reimbursement Listing In China, Set To Launch In 2026
Brief: Cinclus Pharma Recruits Magnus Christensen As New CFO
Brief: Cinclus Pharma Holding Q3 EBIT Loss SEK 44.1 Mln
Brief: Cinclus Pharma Receives Positive FDA Feedback On CMC Meeting
Brief: Cinclus To Start Heealing 1 Phase III Study Of Linaprazan Glurate
Brief: Cinclus Pharma Q2 Net Sales At SEK 34.1 Mln
Brief: Cinclus Pharma Holding Secures EMA And FDA Pediatric Study Waivers For Linaprazan Glurate In H. Pylori Infection
Brief: Cinclus Pharma Partners With Zentiva
Brief: Cinclus Pharma Q1 Operating Loss SEK 47.5 Mln
Brief: Cinclus Pharma Q4 EBIT Loss SEK 56.9 Mln
Brief: Cinclus Pharma's Linaprazan Glurate Gets Marketing Approval In China
Brief: Cinclus Pharma Agrees On Pediatric Study Plan With FDA
Brief: Cinclus Pharma Q3 EBIT Loss Narrows To SEK 39 Mln
Brief: Cinclus Pharma Agrees On Pediatric Investigation Plan With EMA